Posts With Tag AGC Biologics

Genenta Science S.P.A. files Form 6-K detailing a pivotal agreement with AGC Biologics for exclusive manufacturing. This development enhances their clinical programs in Italy.

Explore Genenta Science's latest report detailing the amendment to its ATM Sales Agreement and ongoing negotiations with AGC Biologics, crucial for investors and stakeholders.